70 results on '"Hijazi N"'
Search Results
2. Urban structures and socio-spatial problems in Khartoum urban area : A geographical study
- Author
-
Hijazi, N. B.
- Subjects
301 ,Urban deprivation in Khartoum - Published
- 1981
3. Numeric Evaluation of Backward Wave Propagation Image Reconstruction
- Author
-
McDonald, J. F., Coutts, W., Capsimalis, G., Das, P. K., Hijazi, N. A., Liguori, D. J., Ratnayake, K. B. N., and Kessler, Lawrence W., editor
- Published
- 1988
- Full Text
- View/download PDF
4. Dietary risks
- Author
-
Hijazi, N, Abalkhail, B, and Scaton, A
- Subjects
Asthma in children -- Risk factors ,Risk factors (Health) -- Reports -- Health aspects ,Diseases -- Health aspects -- Risk factors -- Saudi Arabia ,Asthma -- Risk factors ,Health ,Risk factors ,Reports ,Health aspects - Abstract
A high intake of fast food and a low intake of milk, vegetables and fibre are significant risk factors for wheezy disease, according to a study of children in Saudi [...]
- Published
- 2000
5. Index of Suspicion
- Author
-
Rudra, H. S., primary, Park, J. H., additional, Wehbe-Hijazi, N., additional, Alfaifi, M., additional, Alrifai, M., additional, Nazer, D., additional, Srinivasan, L., additional, and Kamat, D., additional
- Published
- 2006
- Full Text
- View/download PDF
6. Improvement on Cluster Based Routing Protocol by Using Vice Cluster Head.
- Author
-
Yassein, M.B. and Hijazi, N.
- Published
- 2010
- Full Text
- View/download PDF
7. IMAGE ACQUISITION AND IMAGE PROCESSING FOR THE INTRAOCULAR VISION AID
- Author
-
Krisch, I., primary, Hijazi, N., additional, and Hosticka, B. J., additional
- Published
- 2002
- Full Text
- View/download PDF
8. WIRELESS POWER AND DATA TRANSMISSION SYSTEM FOR A MICRO IMPLANTABLE INTRAOCULAR VISION AID
- Author
-
Hijazi, N., primary, Krisch, I., additional, and Hosticka, B. J., additional
- Published
- 2002
- Full Text
- View/download PDF
9. Micro implantable visual prostheses.
- Author
-
Schwarz, M., Ewe, L., Hijazi, N., Hosticka, B.J., Huppertz, J., Kolnsberg, S., Mokwa, W., and Trieu, H.K.
- Published
- 2000
- Full Text
- View/download PDF
10. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia
- Author
-
Hijazi, N., primary
- Published
- 2000
- Full Text
- View/download PDF
11. Micro implantable visual prostheses
- Author
-
Schwarz, M., primary, Ewe, L., additional, Hijazi, N., additional, Hosticka, B.J., additional, Huppertz, J., additional, Kolnsberg, S., additional, Mokwa, W., additional, and Trieu, H.K., additional
- Published
- 2000
- Full Text
- View/download PDF
12. Asthma and respiratory symptoms in urban and rural Saudi Arabia
- Author
-
Hijazi, N, primary, Abalkhail, B, additional, and Seaton, A, additional
- Published
- 1998
- Full Text
- View/download PDF
13. Magnitude and orientation of rotation in exchange reactions A+BC→AB+C.
- Author
-
Hijazi, N. H. and Polanyi, J. C.
- Published
- 1975
- Full Text
- View/download PDF
14. Development of nanostructured films based on PLA and chitosan nanoparticles generated by supercritical CO2 assisted processes
- Author
-
Hijazi, N., Nicolas Le Moigne, Rodier, E., Letourneau, J. J., Sauceau, M., Fages, J., Guibal, E., Vincent, T., and Benezet, J. C.
15. α-Defensins induce a post-translational modification of LDL that promotes atherosclerosis at normal levels of plasma cholesterol
- Author
-
Abu-Fanne R, Maraga E, Abd-Elrahman I, Hankin A, Blum G, Abdeen S, Hijazi N, Douglas Cines, and Aa, Higazi
16. Copper binding to PrPC may inhibit prion disease popagation.
- Author
-
Hijazi, N., Shaked, Y., Rosenmann, H., Ben-Hur, T., and Gabizon, R.
- Published
- 2003
17. Two million squatters in Khartoum urban complex: the dilemma of Sudan's national capital
- Author
-
El-Bushra, El-Sayed and Hijazi, N. B.
- Subjects
SOCIOECONOMICS - Published
- 1995
- Full Text
- View/download PDF
18. How certain are we when considering the occurrence of genital ulcers among Israeli Arab female patients with Behçet's disease?
- Author
-
Hassan F, Hijazi N, and Naffaa ME
- Subjects
- Humans, Female, Israel epidemiology, Genital Diseases, Female epidemiology, Genital Diseases, Female etiology, Adult, Behcet Syndrome epidemiology, Behcet Syndrome diagnosis, Arabs statistics & numerical data, Ulcer etiology
- Published
- 2024
19. The Clinical Utility of Powdered and Flowable Matrices in Wound Repair and Tissue Regeneration.
- Author
-
Fierro AL, Hijazi N, Foley C, Rodio L, and Lantis JC 2nd
- Abstract
Cellular and matrix-like products come in many forms. Among them, powdered and micronized formulations have become increasingly available and popular owing to their unique properties and advantages. Powders have increased tissue contact which many believe can enhance granulation tissue formation, they fill irregular and deep cavities, and they can be used in concert with sheet-like products and skin grafts for improved healing. Despite their advantages, powdered products do have certain limitations that hinder their use, including poor insurance coverage and a lack of CPT coding for adequate reimbursement in an outpatient setting, making their use primarily limited to the operating room. Also, most published data on powdered products consists of smaller case studies and case series, with few reports evaluating the efficacy and utility of powdered formulations compared to their sheet-like progenitors. In this manuscript, we organize available powdered matrix products by type of substrate: xenograft, allograft, placental-based, and synthetic, and review the data in support of various products in specific wound types. This review of the supporting literature provides the current body of evidence on the utility of powdered matrices in wounds.
- Published
- 2024
- Full Text
- View/download PDF
20. Clinical outcomes of clostridioides difficile infection in the very elderly.
- Author
-
Kassem S, Hijazi N, Stein N, Zaina A, and Ganaim M
- Subjects
- Humans, Male, Aged, 80 and over, Retrospective Studies, Female, Aged, Clostridioides difficile pathogenicity, Cohort Studies, Risk Factors, Hospital Mortality, Intensive Care Units organization & administration, Intensive Care Units statistics & numerical data, Clostridium Infections epidemiology, Clostridium Infections mortality, Length of Stay statistics & numerical data
- Abstract
Background: Clostridioides difficile infection (CDI) causes considerable morbidity, mortality, and economic cost. Advanced age, prolonged stay in healthcare facility, and exposure to antibiotics are leading risk factors for CDI. Data on CDI clinical outcomes in the very elderly patients are limited., Methods: A retrospective cohort study of patients hospitalized between 2016 and 2018 with CDI. We evaluated demographic clinical and laboratory parameters. Major clinical outcomes were evaluated including duration of hospital stay, admission to intensive care unit (ICU), in-hospital mortality, 30 days post-discharge mortality, and readmission/mortality composite outcome. We compared patients aged up to 80 years (elderly) to those of 80 years old or more (very elderly)., Results: Of 196 patients included in the study, 112 (57%) were very elderly with a mean age of 86 versus 67 years in the elderly group. The duration of hospital stays, and intensive care unit admission frequency were significantly reduced in the very elderly (13 vs. 22 days p = 0.003 and 1.8% vs. 10.7% p = 0.01, respectively). No significant difference was found in the frequencies of in-hospital and in 30 days post-discharge mortality., Conclusions: In our cohort, the duration of hospital stay seemed to be shorter in the very elderly with no increase of in-hospital and post-discharge mortality. Although admitted less frequently to ICU, the in-hospital survival of the very elderly was not adversely affected compared to the elderly, suggesting that very advanced age per se should not be a major factor to consider in determining the prognosis of a patient with CDI., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
21. Titania-zeolite composite for tetracycline photocatalytic degradation under visible light: A comparison between doping and ion exchange.
- Author
-
Jalloul G, Hijazi N, Boyadjian C, Awala H, Albadarin AB, and Ahmad MN
- Abstract
In this study, TiO
2 supported over embryonic Beta zeolite (BEA) was prepared for the photocatalytic degradation of Tetracycline (TC) antibiotic under visible light. The immobilization of sol-gel TiO2 over the zeolite increased its surface area from 33 (m2 /g) to 226 (m2 /g) and enhanced its adsorption efficiency from 8 % to 18 %. In order to expand the photocatalytic activity of TiO2 towards the visible light region (i.e. λ > 380 nm), two different metal sensitization techniques with Iron ions from aqueous solution of FeCl3 were explored. In the ion-exchange method, the substitutional cations within the TiO2 /BEA structure were exchanged with Fe3+ . Whereas, in the doping technique, solgel TiO2 was doped with Fe3+ during its synthesis and before its immobilization over Zeolite. Four different samples with 20, 40, 60, and 100 % w/w of TiO2 /BEA ratio were prepared. After testing the various ion-exchanged photocatalysts under blue and white lights, only Fe-60%TiO2 /BEA showed better activity compared to pure TiO2 under white light at TC initial concentration, Co = 20 ppm. For the doped immobilized Titania with 60 wt% TiO2 /BEA, three different doped photocatalysts were prepared with 3 %, 7 %, and 10 % per mole Fe/TiO2 . All the Fe-doped TiO2 /BEA photocatalysts showed better activity compared to pure TiO2 under white light. Under solar irradiations, the 3 % Fe-doped TiO2 /BEA was able to degrade all TC within 120 min, while Fe-60%TiO2 /BEA needed 200 min, and TiO2 needed more than 300 min. This enhanced performance was a result of both increased surface area due to immobilization over BEA as well as iron doping by Fe3+ that simultaneously increased the visible light absorption of TiO2 and minimized the charge carrier recombination effect., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
22. The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort study.
- Author
-
Hijazi N, Gazitt T, Haddad A, Elias M, Kassem S, Feldhamer I, Cohen AD, Sar S, Tomkins-Netzer O, Saliba W, and Zisman D
- Subjects
- Adult, Female, Humans, Male, Retrospective Studies, Cohort Studies, Etanercept therapeutic use, Case-Control Studies, Risk Factors, Arthritis, Psoriatic complications, Arthritis, Psoriatic drug therapy, Arthritis, Psoriatic epidemiology, Uveitis etiology, Uveitis complications, Biological Products therapeutic use
- Abstract
Objective: To assess the frequency of uveitis in patients with psoriatic arthritis (PsA) in the era of biologics and to identify risk factors associated with uveitis., Methods: A retrospective matched cohort study was conducted within the database of a large healthcare provider. Newly diagnosed 6147 adult PsA patients between 2005 and 2020 were matched by the index date of PsA diagnosis, age, sex, and ethnicity to 23,999 randomly selected controls. This cohort was used to examine the association between PsA and uveitis. An additional analysis was conducted within the PsA group to identify uveitis risk factors, using two analytic approaches: a retrospective cohort study and a nested case-control study., Results: Uveitis was diagnosed in 107 patients in the PsA group (1.7%) vs 187 (0.8%) patients in the control group (adjusted HR, 2.38, 95% CI 1.80-3.15, p<0.005) and was similar when the analysis was confined to patients without past uveitis. Uveitis was diagnosed more in females (2.1% vs 1.3%, HR 1.61, 95% CI 1.09-2.40, p<0.05), and was acute in all cases. Anterior uveitis was documented in 41.1% of the cases, 64.5% unilateral, and 9.3% bilateral. In the PsA group, using nested case control approach, only past uveitis [adjusted OR 136.4 (95% CI 27.38-679.88), p<0.005] and treatment with etanercept [adjusted OR 2.57 (95% CI 1.45-4.57), p=0.001] were independently associated with uveitis. Only one PsA patient with uveitis (out of 107) required systemic oral treatment with prednisone, while the rest of the patients were treated with topical glucocorticosteroids only., Conclusion: PsA is associated with increased risk of uveitis. Past uveitis and treatment with etanercept were associated with higher risk of uveitis. Key Points • Psoriatic arthritis (PsA) is a major risk factor for uveitis with hazard ratio of 2.38 compared to healthy individuals without PsA. • Among PsA patients, the past event of uveitis and treatment with etanercept are risk factors for uveitis. • Uveitis in patients treated with biologics for their PsA requires topical therapy only in most of the cases., (© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).)
- Published
- 2024
- Full Text
- View/download PDF
23. Paxillin regulates liver fibrosis via actin polymerization and ERK activation in hepatic stellate cells.
- Author
-
Hijazi N, Shi Z, and Rockey DC
- Subjects
- Mice, Animals, Paxillin genetics, Paxillin metabolism, Polymerization, Liver Cirrhosis genetics, Liver Cirrhosis metabolism, Liver Cirrhosis pathology, Liver metabolism, Fibrosis, Disease Models, Animal, Actins metabolism, Hepatic Stellate Cells metabolism, Hepatic Stellate Cells pathology
- Abstract
Liver injury leads to fibrosis and cirrhosis. The primary mechanism underlying the fibrogenic response is the activation of hepatic stellate cells (HSCs), which are 'quiescent' in normal liver but become 'activated' after injury by transdifferentiating into extracellular matrix (ECM)-secreting myofibroblasts. Given that integrins are important in HSC activation and fibrogenesis, we hypothesized that paxillin, a key downstream effector in integrin signaling, might be critical in the fibrosis pathway. Using a cell-culture-based model of HSC activation and in vivo models of liver injury, we found that paxillin is upregulated in activated HSCs and fibrotic livers. Overexpression of paxillin (both in vitro and in vivo) led to increased ECM protein expression, and depletion of paxillin in a novel conditional mouse injury model reduced fibrosis. The mechanism by which paxillin mediated this effect appeared to be through the actin cytoskeleton, which signals to the ERK pathway and induces ECM protein production. These data highlight a novel role for paxillin in HSC biology and fibrosis., Competing Interests: Competing interests The authors declare no competing or financial interests., (© 2023. Published by The Company of Biologists Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
24. Real-Life Utilization of Criteria Guidelines for Diagnosis of Cardiac Sarcoidosis (CS).
- Author
-
Gazitt T, Kharouf F, Feld J, Haddad A, Hijazi N, Kibari A, Fuks A, Sabo E, Mor M, Peleg H, Asleh R, and Zisman D
- Abstract
Despite the increasing recognition of cardiac involvement in systemic sarcoidosis, the diagnosis of cardiac sarcoidosis (CS) remains challenging. Our aim is to present a comprehensive, retrospective case series of CS patients, focusing on the current diagnostic guidelines and management of this life-threatening condition. In our case series, patient data were collected retrospectively, including hospital admission records and rheumatology and cardiology clinic visit notes, detailing demographic, clinical, laboratory, pathology, and imaging studies, as well as cardiac devices and prescribed medications. Cases were divided into definite and probable CS based on the 2014 Heart Rhythm Society guidelines as well as presumed CS based on imaging criteria and clinical findings. Overall, 19 CS patients were included, 17 of whom were diagnosed with probable or presumed CS based on cardiac magnetic resonance imaging (CMR) and/or cardiac positron emission tomography using
18 F-Fluorodeoxyglucose (PET-FDG) without supporting endomyocardial biopsy (EMB). The majority of CS patients were male (53%), with a mean age of 52.9 ± 11.8, with CS being the initial manifestation of sarcoidosis in 63% of cases. Most patients presented with high-grade AVB (63%), followed by heart failure (42%) and ventricular tachyarrhythmia (VT) (26%). This case series highlights the significance of utilizing updated diagnostic criteria relying on CMR and PET-FDG given that cardiac involvement can be the initial manifestation of systemic sarcoidosis, requiring prompt diagnosis and treatment to prevent morbidity and mortality.- Published
- 2023
- Full Text
- View/download PDF
25. The Reply.
- Author
-
Kassem S and Hijazi N
- Published
- 2023
- Full Text
- View/download PDF
26. Imaging Pitfalls, When We Should Trust Our Touch.
- Author
-
Zoubi I, Hijazi N, and Kassem S
- Subjects
- Humans, Touch, Trust
- Published
- 2023
- Full Text
- View/download PDF
27. Association of subclinical hypothyroidism with metabolic syndrome components in a group of apparently healthy Syrians: a retrospective cross-sectional study.
- Author
-
Alourfi Z, Hijazi N, and Alsultan M
- Abstract
Thyroid disorders were reported to be associated with various diseases, particularly dyslipidemia. This study aimed to assess the prevalence of thyroid disorders in a group of apparently healthy Syrians and investigate the relationship between subclinical hypothyroidism and metabolic syndrome (MetS)., Methods: A retrospective, cross-sectional study was performed at Al-Assad University Hospital. Participants were healthy individuals aged 18 years and older. Data about their biochemical tests, weight, height, BMI, and blood pressure were collected and analyzed. Participants were categorized according to their thyroid tests into euthyroid, subclinical hypothyroid, subclinical hyperthyroid, and according to their BMI into normal, overweight, and obese, and according to the International Diabetes Foundation into normal and having MetS., Results: A total of 1111 participants were involved in this study. Subclinical hypothyroidism and subclinical hyperthyroidism were found in 4.4 and 1.2% of participants, respectively. The incidence of subclinical hypothyroidism was significantly increased in females and in the presence of positive antithyroid peroxidase. Subclinical hypothyroidism was significantly associated with MetS, a higher waist circumference, central obesity, and triglycerides; however, there was no correlation with high-density lipoprotein., Conclusion: The prevalence of thyroid disorders among Syrians was consistent with the results of other studies. These disorders were significantly more common in females compared to males. Add to that, subclinical hypothyroidism was significantly associated with MetS. Since MetS is a known factor for morbidity and mortality, this may raise the attention needed to perform future prospective trials to evaluate the possible benefits of subclinical hypothyroidism treatment with a low dose of thyroxin., Competing Interests: The author declares that they have no conflicts of interest regarding this study. The author declares that it has not been published elsewhere and that it has not been simultaneously submitted for publication elsewhere.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article., (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2023
- Full Text
- View/download PDF
28. Parental COVID-19 Vaccine Hesitancy for Children and Its Influencing Factors: A Riyadh-Based Cross-Sectional Study.
- Author
-
Almuqbil M, Al-Asmi R, AlRamly S, Hijazi N, Alotaibi H, AlMubarak A, AlAnezi K, Al-Rowaili M, Al-Yamani M, Duwaidi BS, Alshammari DR, Alabdulsalam AM, Almutairi JA, Alasmari FM, and Asdaq SMB
- Abstract
It is well known that vaccination is the best clinical approach for successfully controlling COVID-19 infection. Understanding the disparities in COVID-19 vaccination apprehension among parents in different societies is crucial for effectively implementing COVID-19 vaccination programs. This observational cross-sectional study was carried out in the Riyadh region of Saudi Arabia between February and April 2022. The validated questionnaire was shared with parents who had children between the ages of five and eleven years. The collected data were analyzed using descriptive and inferential statistical methods. Multinomial regression analysis was conducted to determine the factors significantly affecting vaccine-use decisions. Of the 699 participants, 83% of the mothers were between the ages of 35 and 44 years, 67% were university educated, and only 14% were healthcare workers. A large proportion of parents, with an age range of 18-34 years ( p = 0.001), and those with a higher income group ( p = 0.014), demonstrated significant vaccine hesitancy. Further, parents who received one or two vaccination doses were significantly ( p = 0.02) more hesitant than those who received more than two doses of the vaccine. Furthermore, a significantly ( p = 0.002) high percentage of parents who follow the Ministry of Health (MOH) guidelines for personal preventive measures were hesitant about their children's vaccination. Concerns about side effects (31.4%) and a lack of safety data (31.2%) on the COVID-19 vaccines were the two most significant reasons for parents to develop vaccine hesitancy. Social media (24.3%), poor perceived immunity (16.3 %), and news articles (15.5%) were the top three contributors to this hesitancy. Vaccinated parents were 8.21 times more likely to be vaccination-hesitant than non-vaccinated parents. Additionally, parents with less education and a COVID-19-positive child at home increased the odds of vaccine hesitancy by 1.66 and 1.48 times, respectively. Overall, one-third of the parents were not prepared to vaccinate their children, and one-quarter of the respondents had not decided about vaccination. This study shows that parents in Riyadh are generally reluctant to vaccinate their children against COVID-19. As social media is a primary source of information for parents, public health professionals should utilize the platform to encourage parents to support vaccine acceptance.
- Published
- 2023
- Full Text
- View/download PDF
29. Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study.
- Author
-
Gazitt T, Eviatar T, Shear J, Meidan R, Furer V, Feld J, Haddad A, Elias M, Hijazi N, Stein N, Shaked Mishan P, Zetser A, Peleg H, Elkayam O, and Zisman D
- Abstract
Development of autoantibodies following BNT162b2 mRNA COVID-19 vaccination and their association with disease flares in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) and the general population: results of 1-year prospective follow-up study. We conducted a prospective study aimed at investigating the incidence of appearance of autoantibodies (antinuclear, antiphospholipid, and rheumatoid factor) in the sera of 463 adult patients with AIIRD compared to 55 controls from the general population prior to, and following the second and third vaccine doses, and at 1-year of follow-up. Pre- and post-vaccination disease activity indices and the association of autoantibodies with rheumatic disease flares and new onset AIIRD were examined. Autoantibody development of any type in AIIRD patients vs. the controls was 4.0% (vs. 6.7%, p = 0.423) following two vaccine doses and 7.6% (vs. 0%, p = 0.152) after three doses. There was no significant difference in sex, age, or disease-type among individuals with and without autoantibody development, regardless of the immunosuppressant use. More patients developed autoantibodies following the third than the second vaccine dose ( p = 0.004). Disease flares occurred in 5.8% and 7.2% of AIIRD patients following second and third vaccine doses, respectively, with autoantibody production increasing the risk of flares following the second ( p = 0.002) and third ( p = 0.004) vaccine doses. BNT162b2 vaccination resulted in the development of autoantibodies in a minority of AIIRD patients and controls. Autoantibody development was associated with disease flares in patients, but no new-onset autoimmunity was observed.
- Published
- 2023
- Full Text
- View/download PDF
30. Characterization of focal adhesion proteins in rodent hepatic stellate cells.
- Author
-
Hijazi N, Shi Z, and Rockey DC
- Subjects
- Animals, Cells, Cultured, Endothelin-1 metabolism, Integrins metabolism, Ligands, Liver metabolism, RNA, Messenger metabolism, Rats, Rodentia metabolism, Talin metabolism, Transforming Growth Factor beta metabolism, Vinculin metabolism, Focal Adhesions metabolism, Hepatic Stellate Cells metabolism
- Abstract
Ongoing liver injury leads to fibrosis and ultimately cirrhosis, a leading cause of death worldwide. The primary mechanism underlying the fibrogenic response is the activation of cells known as hepatic stellate cells (HSCs) which are "quiescent" in the normal liver but become "activated" after injury by transdifferentiating into extracellular matrix-secreting myofibroblasts. Since integrins (extracellular matrix binding receptors) are important mediators of HSC activation and fibrogenesis, we hypothesized that focal adhesion (FA) proteins, which link integrins to the intracellular protein machinery, may be important in the activation process. Therefore, using both an in vitro model of activation in primary rat HSCs and an in vivo model of liver injury, we examined three FA proteins: vinculin, FAK, and talin. All three proteins were significantly upregulated during HSC activation at both the messenger RNA (mRNA) and protein levels. Confocal microscopy demonstrated that the proteins had a widespread expression throughout HSCs with prominent localization at the end of actin filaments. Finally, we stimulated HSCs with the profibrotic ligands endothelin-1 (ET-1) and transforming growth factor beta (TGF-β) and observed an increase in the size of vinculin-containing FAs and the cell area occupied by them. The data indicate that HSCs possess a broad array of FA proteins, and given their upregulation during activation, this raises the possibility that they play a role in the fibrogenic response to injury., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
31. The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis.
- Author
-
Hijazi N, Rockey DC, and Shi Z
- Abstract
Hepatic stellate cells (HSCs) are the primary effector cells in liver fibrosis. In the normal liver, HSCs serve as the primary vitamin A storage cells in the body and retain a "quiescent" phenotype. However, after liver injury, they transdifferentiate to an "activated" myofibroblast-like phenotype, which is associated with dramatic upregulation of smooth muscle specific actin and extracellular matrix proteins. The result is a fibrotic, stiff, and dysfunctional liver. Therefore, understanding the molecular mechanisms that govern HSC function is essential for the development of anti-fibrotic medications. The actin cytoskeleton has emerged as a key component of the fibrogenic response in wound healing. Recent data indicate that the cytoskeleton receives signals from the cellular microenvironment and translates them to cellular function-in particular, increased type I collagen expression. Dynamic in nature, the actin cytoskeleton continuously polymerizes and depolymerizes in response to changes in the cellular microenvironment. In this viewpoint, we discuss the recent developments underlying cytoskeletal actin dynamics in liver fibrosis, including how the cellular microenvironment affects HSC function and the molecular mechanisms that regulate the actin-induced increase in collagen expression typical of activated HSCs., Competing Interests: Conflicts of Interest: The authors declare that they have no conflicts of interest to report regarding the present study.
- Published
- 2022
- Full Text
- View/download PDF
32. Detection of endocrine disrupting chemicals in Danio rerio and Daphnia pulex: Step-one, behavioral screen.
- Author
-
Alla LNR, Monshi M, Siddiqua Z, Shields J, Alame K, Wahls A, Akemann C, Meyer D, Crofts EJ, Saad F, El-Nachef J, Antoon M, Nakhle R, Hijazi N, Hamid M, Gurdziel K, McElmurry SP, Kashian DR, Baker TR, and Pitts DK
- Subjects
- Animals, Daphnia genetics, Estrone, Zebrafish genetics, Endocrine Disruptors toxicity, Water Pollutants, Chemical analysis, Water Pollutants, Chemical toxicity
- Abstract
Anthropogenic surface and ground water contamination by chemicals is a global problem, and there is an urgent need to develop tools to identify and elucidate biological effects. Contaminants of emerging concern (CECs) are not typically monitored or regulated and those with known or suspected endocrine disrupting potential have been termed endocrine disrupting chemicals (EDCs). Many CECs are known to be neurotoxic (e.g., insecticides) and many are incompletely characterized. Behavioral responses can identify chemicals with neuroactive properties, which can be relevant to EDC mechanisms (e.g., neuroendocrine disturbances). Two freshwater species, Daphnia pulex and Danio rerio, were evaluated for swimming behavior alterations resulting from 24-hr exposure to 9 CECs: triclosan, triclocarban, chlorpyrifos, dieldrin, 4-nonylphenol, bisphenol-A, atrazine, metformin, and estrone. This is the first step in the development of a bioassay for detecting estrogenic and/or anti-androgenic activity with the goal to evaluate complex mixtures of uncharacterized contaminants in water samples. The second step, described in a subsequent report, examines transcriptome alterations following chemical exposure. Significant differences in the swimming behavior response and sensitivity were found across chemicals within a species and across species for a given chemical in this unique optical bioassay system. In the concentration ranges studied, significant behavioral alterations were detected for 6 of 9 CECs for D. pulex and 4 of 9 CECs for D. rerio. These results underscore the utility of this bioassay to identify behavioral effects of sublethal concentrations of CECs before exploration of transcriptomic alterations for EDC detection., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
33. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.
- Author
-
Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, Haddad A, Elias M, Zisman D, Naffaa ME, Brodavka M, Cohen Y, Abu-Much A, Abu Elhija M, Bridgewood C, Langevitz P, McLorinan J, Bragazzi NL, Marzo-Ortega H, Lidar M, Calabrese C, Calabrese L, Vital E, Shoenfeld Y, Amital H, and McGonagle D
- Abstract
Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines is based on either TLR-7/8 or TLR-9 agonism, which is distinct from previous vaccines and is a common pathogenic mechanism in IMDs., Methods: We evaluated IMD flares or new disease onset within 28-days of SARS-CoV-2 vaccination at five large tertiary centres in countries with early vaccination adoption, three in Israel, one in UK, and one in USA. We assessed the pattern of disease expression in terms of autoimmune, autoinflammatory, or mixed disease phenotype and organ system affected. We also evaluated outcomes., Findings: 27 cases included 17 flares and 10 new onset IMDs. 23/27 received the BNT - 162b2 vaccine, 2/27 the mRNA-1273 and 2/27 the ChAdOx1 vaccines. The mean age was 54.4 ± 19.2 years and 55% of cases were female. Among the 27 cases, 21 (78%) had at least one underlying autoimmune/rheumatic disease prior the vaccination. Among those patients with a flare or activation, four episodes occurred after receiving the second-dose and in one patient they occurred both after the first and the second-dose. In those patients with a new onset disease, two occurred after the second-dose and in one patient occurred both after the first (new onset) and second-dose (flare). For either dose, IMDs occurred on average 4 days later. Of the cases, 20/27 (75%) were mild to moderate in severity. Over 80% of cases had excellent resolution of inflammatory features, mostly with the use of corticosteroid therapy. Other immune-mediated conditions included idiopathic pericarditis ( n = 2), neurosarcoidosis with small fiber neuropathy ( n = 1), demyelination ( n = 1), and myasthenia gravis ( n = 2). In 22 cases (81.5%), the insurgence of Adverse event following immunization (AEFI)/IMD could not be explained based on the drug received by the patient. In 23 cases (85.2%), AEFI development could not be explained based on the underlying disease/co-morbidities. Only in one case (3.7%), the timing window of the insurgence of the side effect was considered not compatible with the time from vaccine to flare., Interpretation: Despite the high population exposure in the regions served by these centers, IMDs flares or onset temporally-associated with SARS-CoV-2 vaccination appear rare. Most are moderate in severity and responsive to therapy although some severe flares occurred., Funding: none.
- Published
- 2021
- Full Text
- View/download PDF
34. Pomegranate Juice Extract Decreases Cisplatin Toxicity on Peripheral Blood Mononuclear Cells.
- Author
-
Nasser M, Damaj Z, Hijazi A, Merah O, Al-Khatib B, Hijazi N, Trabolsi C, Damaj R, and Nasser M
- Abstract
Background: Lung cancer is one of the most prevalent cancers worldwide. Chemotherapy regimens, targeted against lung cancer, are considered an effective treatment; albeit with multiple fatal side effects. An alternative strategy, nowadays, is using natural products. Medicinal plants have been used, in combination with chemotherapy, to ameliorate side effects., Aims: This study aims to investigate the antitumor effect of pomegranate juice ( Punica granatum ) on human lung adenocarcinoma basal epithelial cells (A549), to check the effect, when combined with low dose cisplatin (CDDP), at different doses. We also have evaluated the potential protective effect of pomegranate on normal peripheral blood mononuclear cells (PBMC)., Methods: Phytochemical screening of the extract was done using standard classical tests. Total phenolic and sugar contents were determined using the Folin-Ciocalteu and anthrone reagents, respectively. The antioxidant activity of pomegranate was estimated by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. The viability of A549 cells and PBMC was evaluated using the neutral red assay., Results: Our results demonstrated that Punica granatum or pomegranate juice (with different concentrations: 150, 300, 600 µg/mL) contained high levels of flavonoids, alkaloids, tanins, lignins, terpenoids, and phenols. The DPPH method showed that pomegranate juice had a strong antioxidant scavenging activity. Neutral red showed that combining pomegranate juice with low dose CDDP (8 µg/mL) decreased the cell viability of A549 cells, by 64%, compared to treatment with CDDP or pomegranate alone. When added to low dose CDDP, pomegranate increased the viability of normal PBMC cells by 46%., Conclusions: These results demonstrated that pomegranate could potentiate the anticancer effect of low dose CDDP on human lung adenocarcinoma cells (A549 cells) and could as well decrease its toxicity on PBMC.
- Published
- 2020
- Full Text
- View/download PDF
35. Association between Hypertension, Antihypertensive Drugs, and Osteoporosis in Postmenopausal Syrian Women: A Cross-Sectional Study.
- Author
-
Hijazi N and Alourfi Z
- Abstract
Background: Osteoporosis and hypertension are frequent and often coexisting diseases among the elderly. Recent studies suggested that both diseases may share the same etiopathology. Moreover, the treatment of hypertension can affect the bone mineral density and worsen osteoporosis. The aim of this cross-sectional study was to assess the prevalence of low bone mass and osteoporosis in postmenopausal Syrian women and investigate their relationship with hypertension and antihypertensive drugs., Methods: 813 postmenopausal women were involved in this cross-sectional study, aged between 40 and 96 yrs. Their menopause duration ranged between 1 and 43 yrs. Bone mineral density was measured using a dual-energy X-ray absorptiometry at the total lumbar spine (L1-L4) and left hip. T-score values were used to determine the diagnosis of osteoporosis. The existence of HTN was defined as blood pressure ≥130/85 mmHg or a history of hypertension medication., Results: Using the world health organization criteria, 24% had osteoporosis and 45.2% had low bone mass. The incidence of osteoporosis and low bone mass significantly increased with age and menopause duration and decreased with BMI. Prevalence of hypertension was almost equal among the women who had or did not have osteoporosis. However, hypertensive women who used thiazides or beta blockers had higher values of total lumbar BMD compared with the women who did not., Conclusion: Hypertension in postmenopausal Syrian women aged over 40 was not found to be associated with osteoporosis. However, the mean total lumbar BMD of the hypertensive women who took thiazide diuretics or beta blocker was found to be increased significantly comparing to the women who did not take either., Competing Interests: Authors declare no conflicts of interest., (Copyright © 2020 Nermeen Hijazi and Zaynab Alourfi.)
- Published
- 2020
- Full Text
- View/download PDF
36. Diagnostic Dilemma in Two Cases of Hyperandrogenism.
- Author
-
Alali I, Haj Hassan L, Mardini G, Hijazi N, Hadid L, and Kabalan Y
- Abstract
Hirsutism is a common endocrine complaint affecting about 10 percent of women. It may be caused by multiple etiologies including adrenal and ovarian disorders. Usually, it is a result of a benign entity such as PCOs and idiopathic hirsutism. However, sometimes especially when it is severe and rapid in progression an androgen-secreting tumor should be excluded. Sertoli-Leydig cell tumors constitute fewer than 0.5 percent of ovarian tumors and it may be benign or malignant. In this article, we present two cases of hyperandrogenism caused by occult ovarian Leydig cell tumors. one of them was confounded by the presence of coincidental bilateral adrenal nodules that complicated the diagnostic process. Tumor dissection was curative in both cases and the diagnosis was confirmed by pathological and hormonal testing after surgery.
- Published
- 2018
- Full Text
- View/download PDF
37. Epstein-Barr virus-positive follicular lymphoma.
- Author
-
Mackrides N, Campuzano-Zuluaga G, Maque-Acosta Y, Moul A, Hijazi N, Ikpatt FO, Levy R, Verdun RE, Kunkalla K, Natkunam Y, Lossos IS, Vega F, and Chapman J
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Lymphoma, Follicular pathology, Lymphoma, Large B-Cell, Diffuse pathology, Male, Middle Aged, Herpesvirus 4, Human isolation & purification, Lymphoma, Follicular virology, Lymphoma, Large B-Cell, Diffuse virology
- Abstract
Epstein-Barr virus (EBV) -associated follicular lymphoma is only rarely reported. Herein, we report the largest series analyzing prevalence and clinicopathologic characteristics of EBV-associated follicular lymphoma occurring in unselected cases. Out of 382 analyzed cases, 10 EBV-positive follicular lymphomas were identified (prevalence=2.6%, 95% confidence interval 1.3-4.0%). All EBV-positive follicular lymphomas showed EBV-encoded small RNA-positive lymphoma cells present in a follicular distribution. Of these, eight also had tissue available for testing of expression of latent membrane protein 1 (LMP1), out of which six (75%) were positive. There was a significant association with grades 3A-3B follicular lymphoma (P<0.0001) and CD30 expression (P=0.0002). EBV-positive follicular lymphomas were otherwise morphologically and immunophenotypically indistinguishable from EBV-negative cases of similar grade. Nine of the EBV-positive follicular lymphomas occurred in patients with no known history of immunosuppression, while one patient had a history of hydroxychloroquine administration for Sjögren's syndrome. The mean age in the EBV-positive and -negative follicular lymphomas was 56 (range 31-83 years) and 49 years (range 25-92 years), respectively, with no statistically significant difference. Seven of the patients with EBV-positive follicular lymphoma had additional biopsies from different time points available for review, all of which showed progression of disease in the form of progression of tumor grade. Five of these progressed to diffuse large B-cell lymphoma, one of which had tissue available for testing and was EBV-positive. Our findings suggest that EBV infection may have a role in lymphomagenesis and/or disease progression in a subset of follicular lymphomas, thereby expanding the spectrum of recognized EBV-associated B-cell lymphomas.
- Published
- 2017
- Full Text
- View/download PDF
38. Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms.
- Author
-
Lazova R, Seeley EH, Kutzner H, Scolyer RA, Scott G, Cerroni L, Fried I, Kozovska ME, Rosenberg AS, Prieto VG, Shehata BM, Durham MM, Henry G, Rodriguez-Peralto JL, Riveiro-Falkenbach E, Schaefer JT, Danialan R, Fraitag S, Vollenweider-Roten S, Sepehr A, Sangueza M, Hijazi N, Corredoira Y, Kowal R, Harris OM, Bravo F, Boyd AS, Gueorguieva R, and Caprioli RM
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Child, Child, Preschool, Diagnosis, Differential, Female, Humans, Lymphatic Metastasis, Male, Melanoma chemistry, Middle Aged, Neoplasm Recurrence, Local chemistry, Nevus, Epithelioid and Spindle Cell chemistry, Proteins analysis, Retrospective Studies, Risk Assessment, Sentinel Lymph Node Biopsy, Skin Neoplasms chemistry, Treatment Outcome, Tumor Burden, Young Adult, Mass Spectrometry, Melanoma diagnostic imaging, Melanoma secondary, Neoplasm Recurrence, Local diagnostic imaging, Neoplasm Recurrence, Local pathology, Nevus, Epithelioid and Spindle Cell diagnostic imaging, Nevus, Epithelioid and Spindle Cell pathology, Skin Neoplasms diagnostic imaging, Skin Neoplasms pathology
- Abstract
Background: Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas., Objective: We sought to determine whether IMS can assist in the classification of diagnostically challenging atypical Spitzoid neoplasms (ASN), to compare and correlate the IMS and histopathological diagnoses with clinical behavior., Methods: We conducted a retrospective collaborative study involving centers from 11 countries and 11 US institutions analyzing 102 ASNs by IMS. Patients were divided into clinical groups 1 to 4 representing best to worst clinical behavior. The association among IMS findings, histopathological diagnoses, and clinical groups was assessed., Results: There was a strong association between a diagnosis of Spitzoid melanoma by IMS and lesions categorized as clinical groups 2, 3, and 4 (recurrence of disease, metastases, or death) compared with clinical group 1 (no recurrence or metastasis beyond a sentinel node) (P < .0001). Older age and greater tumor thickness were strongly associated with poorer outcome (P = .01)., Conclusions: IMS diagnosis of ASN better predicted clinical outcome than histopathology. Diagnosis of Spitzoid melanoma by IMS was strongly associated with aggressive clinical behavior. IMS analysis using a proteomic signature may improve the diagnosis and prediction of outcome/risk stratification for patients with ASN., (Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
39. α-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol.
- Author
-
Abu-Fanne R, Maraga E, Abd-Elrahman I, Hankin A, Blum G, Abdeen S, Hijazi N, Cines DB, and Higazi AA
- Subjects
- Animals, Atherosclerosis genetics, Atherosclerosis pathology, Cathepsins blood, Cathepsins genetics, Cholesterol genetics, Colchicine pharmacology, Endothelial Cells pathology, Humans, Inflammation blood, Inflammation genetics, Inflammation pathology, Lipoproteins, LDL genetics, Male, Mice, Mice, Transgenic, Multiprotein Complexes blood, Multiprotein Complexes genetics, alpha-Defensins genetics, Atherosclerosis blood, Cholesterol blood, Endothelial Cells metabolism, Lipoproteins, LDL blood, Protein Processing, Post-Translational, alpha-Defensins blood
- Abstract
Approximately one-half of the patients who develop clinical atherosclerosis have normal or only modest elevations in plasma lipids, indicating that additional mechanisms contribute to pathogenesis. In view of increasing evidence that inflammation contributes to atherogenesis, we studied the effect of human neutrophil α-defensins on low density lipoprotein (LDL) trafficking, metabolism, vascular deposition, and atherogenesis using transgenic mice expressing human α-defensins in their polymorphonuclear leukocytes (Def(+/+)). Accelerated Def(+/+) mice developed α-defensin·LDL complexes that accelerate the clearance of LDL from the circulation accompanied by enhanced vascular deposition and retention of LDL, induction of endothelial cathepsins, increased endothelial permeability to LDL, and the development of lipid streaks in the aortic roots when fed a regular diet and at normal plasma levels of LDL. Transplantation of bone marrow from Def(+/+) to WT mice increased LDL clearance, increased vascular permeability, and increased vascular deposition of LDL, whereas transplantation of WT bone marrow to Def(+/+) mice prevented these outcomes. The same outcome was obtained by treating Def(+/+) mice with colchicine to inhibit the release of α-defensins. These studies identify a potential new link between inflammation and the development of atherosclerosis., (© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
40. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.
- Author
-
Hijazi N, Abu Fanne R, Abramovitch R, Yarovoi S, Higazi M, Abdeen S, Basheer M, Maraga E, Cines DB, and Higazi AA
- Subjects
- Animals, Antifibrinolytic Agents pharmacology, Brain blood supply, Brain metabolism, Brain Injuries blood, Cerebral Hemorrhage etiology, Cerebral Hemorrhage genetics, Fibrin metabolism, Fibrinolysis drug effects, Humans, Male, Mice, Inbred C57BL, Mice, Knockout, Mutation, Plasminogen metabolism, Plasminogen Activator Inhibitor 1 genetics, Plasminogen Activator Inhibitor 1 metabolism, Protein Binding, Time Factors, Tissue Plasminogen Activator genetics, Tranexamic Acid pharmacology, Urokinase-Type Plasminogen Activator genetics, Brain Injuries complications, Cerebral Hemorrhage metabolism, Tissue Plasminogen Activator metabolism, Urokinase-Type Plasminogen Activator metabolism
- Abstract
Persistent intracerebral hemorrhage (ICH) is a major cause of death and disability after traumatic brain injury (TBI) for which no medical treatment is available. Delayed bleeding is often ascribed to consumptive coagulopathy initiated by exposed brain tissue factor. We examined an alternative hypothesis, namely, that marked release of tissue-type plasminogen activator (tPA) followed by delayed synthesis and release of urokinase plasminogen activator (uPA) from injured brain leads to posttraumatic bleeding by causing premature clot lysis. Using a murine model of severe TBI, we found that ICH is reduced in tPA(-/-) and uPA(-/-) mice but increased in PAI-1(-/-) mice compared with wild-type (WT) mice. tPA(-/-), but not uPA(-/-), mice developed a systemic coagulopathy post-TBI. Tranexamic acid inhibited ICH expansion in uPA(-/-)mice but not in tPA(-/-) mice. Catalytically inactive tPA-S(481)A inhibited plasminogen activation by tPA and uPA, attenuated ICH, lowered plasma d-dimers, lessened thrombocytopenia, and improved neurologic outcome in WT, tPA(-/-), and uPA(-/-) mice. ICH expansion was also inhibited by tPA-S(481)A in WT mice anticoagulated with warfarin. These data demonstrate that protracted endogenous fibrinolysis induced by TBI is primarily responsible for persistent ICH and post-TBI coagulopathy in this model and offer a novel approach to interrupt bleeding., (© 2015 by The American Society of Hematology.)
- Published
- 2015
- Full Text
- View/download PDF
41. The significance of Melan-A-positive pagetoid melanocytosis in dysplastic nevi.
- Author
-
Huwait H, Hijazi N, Martinka M, and Crawford RI
- Subjects
- Adolescent, Adult, Aged, Biomarkers metabolism, Biopsy, Diagnosis, Differential, Diagnostic Errors prevention & control, Dysplastic Nevus Syndrome diagnosis, Female, Humans, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, Skin pathology, Young Adult, Dysplastic Nevus Syndrome metabolism, Dysplastic Nevus Syndrome pathology, MART-1 Antigen metabolism, Melanocytes metabolism, Melanocytes pathology
- Abstract
Dysplastic nevi may occasionally display alarming histological features. One of these features is the presence of upward spread of melanocytes (pagetoid melanocytosis), identified either on routine histologic sections or after immunohistochemistry using one of the melanocytic markers. Forty-three cases of dysplastic nevi with mild to moderate atypia were selected and retrieved, and Melan-A staining was performed. Melan-A-positive cells with pagetoid architecture were present in 27 cases (63%). Of these, only 5 cases demonstrated pagetoid architecture on routine staining. It is concluded that Melan-A staining should be used only with caution as an adjunct to routine histology in the evaluation of dysplastic nevi with mild to moderate atypia because the identification of pagetoid melanocytosis using this technique has the potential to lead to an erroneous diagnosis of melanoma.
- Published
- 2014
- Full Text
- View/download PDF
42. Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate.
- Author
-
Fanne RA, Nassar T, Heyman SN, Hijazi N, and Higazi AA
- Subjects
- Analysis of Variance, Animals, Blood Glucose drug effects, Blood Glucose metabolism, Brain metabolism, Brain pathology, Brain physiopathology, Diabetes Mellitus, Experimental blood, Diabetes Mellitus, Experimental cerebrospinal fluid, Glucagon administration & dosage, Glutamic Acid blood, Glutamic Acid cerebrospinal fluid, Hypoglycemic Agents administration & dosage, Infarction, Middle Cerebral Artery blood, Infarction, Middle Cerebral Artery cerebrospinal fluid, Infarction, Middle Cerebral Artery pathology, Infarction, Middle Cerebral Artery physiopathology, Insulin administration & dosage, Male, Neuroprotective Agents administration & dosage, Oxaloacetic Acid pharmacology, Rats, Rats, Sprague-Dawley, Time Factors, Brain drug effects, Diabetes Mellitus, Experimental drug therapy, Glucagon pharmacology, Glutamic Acid metabolism, Hypoglycemic Agents pharmacology, Infarction, Middle Cerebral Artery drug therapy, Insulin pharmacology, Neuroprotective Agents pharmacology
- Abstract
In patients with acute ischemic stroke, diabetes and hyperglycemia are associated with increased infarct size, more profound neurologic deficits and higher mortality. Notwithstanding extensive clinical and experimental data, treatment of stroke-associated hyperglycemia with insulin is controversial. In addition to hyperglycemia, diabetes and even early prediabetic insulin resistance are associated with increased levels of amino acids, including the neurotoxic glutamate, in the circulation. The pleiotropic metabolic effects of insulin include a reduction in the concentration of amino acids in the circulation. In this article, we show that in diabetic rats exposed to transient middle cerebral artery occlusion, a decrease of plasma glutamate by insulin or glucagon reduces CSF glutamate, improves brain histology, and preserves neurologic function. The neuroprotective effect of insulin and glucagon was similar, notwithstanding their opposite effects on blood glucose. The therapeutic window of both hormones overlapped with the short duration (~30 min) of elevated brain glutamate following brain trauma in rodents. Similar neuroprotective effects were found after administration of the glutamate scavenger oxaloacetate, which does not affect glucose metabolism. These data indicate that insulin and glucagon exert a neuroprotective effect within a very brief therapeutic window that correlates with their capacity to reduce glutamate, rather than by modifying glucose levels.
- Published
- 2011
- Full Text
- View/download PDF
43. Neuroprotection by glucagon: role of gluconeogenesis.
- Author
-
Fanne RA, Nassar T, Mazuz A, Waked O, Heyman SN, Hijazi N, Goelman G, and Higazi AA
- Subjects
- Animals, Brain Injuries metabolism, Glucagon administration & dosage, Gluconeogenesis physiology, Glucose metabolism, Glutamates metabolism, Head Injuries, Closed metabolism, Injections, Intraperitoneal, Liver metabolism, Male, Mice, Mice, Inbred C57BL, Models, Animal, Neuroprotective Agents administration & dosage, Brain Injuries prevention & control, Glucagon pharmacology, Gluconeogenesis drug effects, Head Injuries, Closed prevention & control, Neuroprotective Agents pharmacology
- Abstract
Object: The severity of neurological impairment following traumatic brain injury (TBI) is exacerbated by several endogenous processes, including hyperglycemia, hypotension, and the generation of glutamate. However, in addition to controlling hyperglycemia, insulin has pleiotropic effects on tissue metabolism, which include reducing the concentration of the neurotoxic amino acid glutamate, making it unclear whether insulin's beneficial effects are attributable to the establishment of euglycemia per se. In the present study, the authors asked if reducing glutamate via approaches that do not lower glucose levels would improve neurological outcome following TBI., Methods: Glucagon activates gluconeogenesis by increasing the hepatic uptake of amino acids such as glutamate and facilitating their conversion to glucose. Glucagon was administered as a single intraperitoneal injection before or after closed head injury (CHI). Neurological function, brain histological features, blood glutamate and glucose levels, and CSF glutamate concentrations were measured., Results: A single intraperitoneal injection of glucagon (25 μg) into mice 10 minutes before or after CHI reduced lesion size by about 60% (p < 0.0001) and accelerated neurological recovery. The neuroprotective effect of glucagon was related to gluconeogenesis by decreasing the concentration of the neuroexcitatory amino acid glutamate in the circulation from 207 ± 32.1 μmol/L in untreated mice to 101.11 ± 21.6 μmol/L in treated mice (p < 0.001); a similar effect occurred in the CSF. The neuroprotective effect of glucagon was seen notwithstanding the attendant increase in blood glucose, the final substrate of gluconeogenesis., Conclusions: Glucagon exerts a marked neuroprotective effect post-TBI by decreasing CNS glutamate. Glucagon was beneficial despite increasing blood glucose. Favorable effects also occurred when glucagon was given prior to TBI, suggesting its involvement in the preconditioning process. Thus, glucagon may be of value in providing neuroprotection when administered after TBI or prior to certain neurosurgical or cardiac interventions in which the incidence of perioperative ischemia is high.
- Published
- 2011
- Full Text
- View/download PDF
44. Case 2: Bizarre behaviour in a three-year-old child.
- Author
-
Wehbe-Hijazi N
- Published
- 2008
- Full Text
- View/download PDF
45. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression.
- Author
-
Hijazi N, Kariv-Inbal Z, Gasset M, and Gabizon R
- Subjects
- Animals, Brain metabolism, CHO Cells, Cricetinae, Dose-Response Relationship, Drug, Heparin chemistry, Heparin metabolism, Mesocricetus, Mice, Prions chemistry, Prions metabolism, Protein Binding, Scrapie metabolism, Sepharose chemistry, Temperature, Glycosaminoglycans metabolism, PrPSc Proteins metabolism
- Abstract
Many lines of evidence suggest an interaction between glycosaminoglycans (GAGs) and the PrP proteins as well as a possible role for GAGs in prion disease pathogenesis. In this work, we sought to determine whether the PrP-GAG interaction affects the incorporation of PrP(Sc) (the scrapie isoform of PrP) to normal cells. This may be the first step in prion disease pathogenesis. To this effect, we incubated proteinase K-digested hamster scrapie brain homogenates with several lines of Chinese hamster ovary (CHO) cells in the presence or absence of heparin. Our results show that over a large range of PrP(Sc) concentrations the binding of PrP(Sc) to wild type CHO cells, which do not express detectable PrP, was equivalent to the binding of PrP(Sc) to CHO cells overexpressing PrP. A significant part of PrP(Sc) binding to both lines could be inhibited by heparin. Additional evidence that PrP(Sc) binding to cells was dependent on the presence of GAGs could be concluded from the fact that the binding of PrP(Sc) to CHO cells missing GAGs on the cell surface was significantly reduced. Interestingly, preincubation of scrapie brain homogenate with heparin before intraperitoneal inoculation into normal hamsters resulted in a significant delay in prion disease manifestation.
- Published
- 2005
- Full Text
- View/download PDF
46. Copper binding to PrPC may inhibit prion disease propagation.
- Author
-
Hijazi N, Shaked Y, Rosenmann H, Ben-Hur T, and Gabizon R
- Subjects
- Animals, Brain drug effects, Brain metabolism, Brain pathology, Cell Line, Copper Sulfate administration & dosage, Cricetinae, Dose-Response Relationship, Drug, Humans, Immunoblotting methods, Immunohistochemistry methods, Infections, Male, Microscopy, Confocal methods, PrPSc Proteins drug effects, PrPSc Proteins genetics, Protein Binding drug effects, Protein Transport drug effects, Purkinje Cells pathology, RNA, Messenger biosynthesis, Reverse Transcriptase Polymerase Chain Reaction methods, Spectrophotometry, Atomic methods, Time Factors, Copper Sulfate therapeutic use, PrPC Proteins metabolism, PrPSc Proteins metabolism, Prion Diseases prevention & control
- Abstract
Although it has been well established that PrP(C), the normal isoform of PrP(Sc), is a copper-binding protein, the role of this metal in the function of PrP(C) as well as in prion disease pathology remains unclear. Here, we show that when scrapie-infected neuroblastoma cells were cultured in the presence of copper, the accumulation of PrP(Sc) in these cells was markedly reduced. In addition, our results indicate that when normal neuroblastoma cells were cultured in the presence of copper ions, they could no longer bind and internalize PrP(Sc). In another set of experiments, copper was added to the drinking water of normal and scrapie-infected hamsters. Our results show that administration of copper to normal hamsters induced cerebellar PrP(C) accumulation. Most important, a significant delay in prion disease onset was observed when scrapie-infected hamsters were treated with copper. As shown before for neuroblastoma cells, also in vivo most of the copper-induced accumulation of PrP(C) was intracellular. We hypothesized that PrP(C) internalization by copper may hinder PrP(Sc) interaction with this molecule, and thereby affect prion disease propagation.
- Published
- 2003
- Full Text
- View/download PDF
47. Transcription levels of Pseudomonas aeruginosa exotoxin a gene and severity of symptoms in patients with otitis externa.
- Author
-
Matar GM, Ramlawi F, Hijazi N, Khneisser I, and Abdelnoor AM
- Subjects
- ADP Ribose Transferases biosynthesis, Bacterial Toxins biosynthesis, DNA, Bacterial chemistry, DNA, Bacterial genetics, DNA, Complementary chemistry, DNA, Complementary genetics, Electrophoresis, Agar Gel, Exotoxins biosynthesis, Humans, Image Processing, Computer-Assisted, Pseudomonas aeruginosa metabolism, Pseudomonas aeruginosa pathogenicity, RNA, Bacterial chemistry, RNA, Bacterial genetics, Reverse Transcriptase Polymerase Chain Reaction, Transcription, Genetic, Virulence genetics, Virulence physiology, Virulence Factors biosynthesis, Pseudomonas aeruginosa Exotoxin A, ADP Ribose Transferases genetics, Bacterial Toxins genetics, Exotoxins genetics, Otitis Externa microbiology, Pseudomonas aeruginosa genetics, Virulence Factors genetics
- Abstract
Polymerase chain reaction (PCR)-based detection and transcription of the gene encoding a potent virulence factor, the exotoxin A, were done on 32 isolates of Pseudomonas aeruginosa belonging to 23 genotypes. These isolates were obtained from 22 patients who were admitted to the emergency room in a medical center during a 5-month period with the diagnosis of either unilateral or bilateral otitis externa. Patients showed symptoms that ranged from mild to severe. PCR amplification of a 396-bp fragment of the gene encoding the exotoxin A was done on extracted DNA. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) was performed on extracted RNA to detect exotoxin A gene mRNA transcripts. Quantitation of RT-PCR amplicons from P. aeruginosa isolates associated with mild and severe symptoms was determined by end-point titration of c-DNA and scanning of amplicons with the Storm Gel and Blot Imaging System. Data have shown that all of the 32 isolates of P. aeruginosa carry the exotoxin A gene, and all isolates with the exception of two had the exotoxin A transcription demonstrated by the production of a 396-bp amplicon from RT-PCR-amplified RNA. The remaining two isolates amplified fragments that were slightly smaller than the expected size. Additional studies are needed to characterize these two mRNA transcripts. Transcription levels of exotoxin A gene associated with severe symptoms were significantly more elevated than those associated with mild to moderate symptoms. Studies are under way to determine expression of P. aeruginosa exotoxin A by detecting quantitatively levels of the translated exotoxin A protein produced by isolates associated with severe and mild to moderate symptoms.
- Published
- 2002
- Full Text
- View/download PDF
48. Doppel and PrP(C) do not share the same membrane microenvironment.
- Author
-
Shaked Y, Hijazi N, and Gabizon R
- Subjects
- Animals, Chromatography, Affinity, GPI-Linked Proteins, Mice, PrPC Proteins chemistry, Precipitin Tests, Prions chemistry, Protein Structure, Tertiary, PrPC Proteins physiology, Prions physiology
- Abstract
Doppel is a paralog of the normal prion protein, PrP(C). It has been suggested that Doppel can compensate for the absence of PrP(C) in PrP(0/0) mice. In this work, we tested whether Doppel and PrP(C) share the same cell location, thereby sharing the same neighboring cell components, probably required to share the same cell function. Our results show that, at detergent conditions in which membrane rafts were intact, neither PrP(C) and Doppel co-immunoprecipitate with the appropriate antibodies, nor was Doppel retained by a Cu(2+)IMAC resin, as PrP(C) does. This indicates that, although Doppel is a raft-associated protein as is PrP(C), both proteins are not present in the same membrane microenvironment, and they probably do not perform the same function.
- Published
- 2002
- Full Text
- View/download PDF
49. Image acquisition and image processing for the intraocular vision aid.
- Author
-
Krisch I, Hijazi N, and Hosticka BJ
- Subjects
- Computer Systems, Humans, Corneal Opacity rehabilitation, Image Processing, Computer-Assisted instrumentation, Microcomputers, Miniaturization instrumentation, Prostheses and Implants, Sensory Aids
- Abstract
The contribution describes an "intraocular vision aid (IOVA)" system for patients suffering from corneal opacification. In order to gain patients' acceptance the system has to be miniaturized to a magnitude that image acquisition, image processing, and power supply can be integrated into a portable unit. A CMOS camera whose dynamic range covers more than 100 dB takes pictures of the scenery. Its image sensor has a resolution of 380 x 300 pixel. In order to reduce fixed pattern noise correlated double sampling is implemented on-chip. In addition, this sensor stands out for low power consumption, random pixel access, and local brightness adaptation. An analog-digital-converter allows direct coupling to an external signal processor or a monolithically integrated unit for image processing to compress data.
- Published
- 2002
- Full Text
- View/download PDF
50. Wireless power and data transmission system for a micro implantable intraocular vision aid.
- Author
-
Hijazi N, Krisch I, and Hosticka BJ
- Subjects
- Equipment Design, Humans, Corneal Opacity rehabilitation, Microcomputers, Miniaturization instrumentation, Prostheses and Implants, Sensory Aids
- Abstract
Wireless power and data transmission system developed for an intraocular vision aid for blind patients will be described. This system is applicable for patients suffering from bilateral corneal opacification but with intact posterior ocular. The system consists of an external unit as well as an implant. The external unit is required for image acquisition, channel coding, IR data transmission, and RF power transmission to the implant. The implantable unit contains a CMOS receiver, a receiver antenna coil, and the microdisplay based on a LED array. The CMOS receiver serves for reception and decoding of image data as well as driving circuits for the miniaturized LED array. In this case, mechanical wiring between the external unit and the implant is neither useful nor comfortable. An optimal technical solution needs a wireless data transfer. If the power is transferred to the implant wireless, too, the solution grows ideal. The system described in this communication employs wireless power and data transmission using an 13.56 MHz RF link for power transmission and an near IR (NIR) optical link for data transmission from an external CMOS camera and telemetry unit to the implantable micro display.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.